797 related articles for article (PubMed ID: 18363936)
1. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.
Weller RO; Subash M; Preston SD; Mazanti I; Carare RO
Brain Pathol; 2008 Apr; 18(2):253-66. PubMed ID: 18363936
[TBL] [Abstract][Full Text] [Related]
2. Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy.
Hawkes CA; Jayakody N; Johnston DA; Bechmann I; Carare RO
Brain Pathol; 2014 Jul; 24(4):396-403. PubMed ID: 24946077
[TBL] [Abstract][Full Text] [Related]
3. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.
Weller RO; Boche D; Nicoll JA
Acta Neuropathol; 2009 Jul; 118(1):87-102. PubMed ID: 19234858
[TBL] [Abstract][Full Text] [Related]
4. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain.
Preston SD; Steart PV; Wilkinson A; Nicoll JA; Weller RO
Neuropathol Appl Neurobiol; 2003 Apr; 29(2):106-17. PubMed ID: 12662319
[TBL] [Abstract][Full Text] [Related]
5. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.
Keable A; Fenna K; Yuen HM; Johnston DA; Smyth NR; Smith C; Al-Shahi Salman R; Samarasekera N; Nicoll JA; Attems J; Kalaria RN; Weller RO; Carare RO
Biochim Biophys Acta; 2016 May; 1862(5):1037-46. PubMed ID: 26327684
[TBL] [Abstract][Full Text] [Related]
6. Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease.
Zekonyte J; Sakai K; Nicoll JA; Weller RO; Carare RO
Biochim Biophys Acta; 2016 May; 1862(5):1047-53. PubMed ID: 26327683
[TBL] [Abstract][Full Text] [Related]
7. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain.
Weller RO; Nicoll JA
Neurol Res; 2003 Sep; 25(6):611-6. PubMed ID: 14503015
[TBL] [Abstract][Full Text] [Related]
8. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease.
Weller RO; Preston SD; Subash M; Carare RO
Alzheimers Res Ther; 2009 Oct; 1(2):6. PubMed ID: 19822028
[TBL] [Abstract][Full Text] [Related]
9. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models.
Arbel-Ornath M; Hudry E; Eikermann-Haerter K; Hou S; Gregory JL; Zhao L; Betensky RA; Frosch MP; Greenberg SM; Bacskai BJ
Acta Neuropathol; 2013 Sep; 126(3):353-64. PubMed ID: 23818064
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease.
Weller RO; Yow HY; Preston SD; Mazanti I; Nicoll JA
Ann N Y Acad Sci; 2002 Nov; 977():162-8. PubMed ID: 12480747
[TBL] [Abstract][Full Text] [Related]
11. High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease.
Soontornniyomkij V; Choi C; Pomakian J; Vinters HV
Hum Pathol; 2010 Nov; 41(11):1601-8. PubMed ID: 20688356
[TBL] [Abstract][Full Text] [Related]
12. Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-β from the mouse brain.
Hawkes CA; Gatherer M; Sharp MM; Dorr A; Yuen HM; Kalaria R; Weller RO; Carare RO
Aging Cell; 2013 Apr; 12(2):224-36. PubMed ID: 23413811
[TBL] [Abstract][Full Text] [Related]
13. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.
Weller RO; Massey A; Newman TA; Hutchings M; Kuo YM; Roher AE
Am J Pathol; 1998 Sep; 153(3):725-33. PubMed ID: 9736023
[TBL] [Abstract][Full Text] [Related]
14. Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease.
Weller RO; Massey A; Kuo YM; Roher AE
Ann N Y Acad Sci; 2000 Apr; 903():110-7. PubMed ID: 10818495
[TBL] [Abstract][Full Text] [Related]
15. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease.
Roher AE; Kuo YM; Esh C; Knebel C; Weiss N; Kalback W; Luehrs DC; Childress JL; Beach TG; Weller RO; Kokjohn TA
Mol Med; 2003; 9(3-4):112-22. PubMed ID: 12865947
[TBL] [Abstract][Full Text] [Related]
16. Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer's disease mouse model.
Kim SH; Ahn JH; Yang H; Lee P; Koh GY; Jeong Y
Acta Neuropathol Commun; 2020 Nov; 8(1):181. PubMed ID: 33153499
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of dementias and implications for therapy.
Roy OW; Cohen NR; Nicoll JA
Indian J Pathol Microbiol; 2005 Jul; 48(3):289-99. PubMed ID: 16761736
[TBL] [Abstract][Full Text] [Related]
18. Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer's disease.
Carare RO; Teeling JL; Hawkes CA; Püntener U; Weller RO; Nicoll JA; Perry VH
Acta Neuropathol Commun; 2013 Aug; 1():48. PubMed ID: 24252464
[TBL] [Abstract][Full Text] [Related]
19. Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring.
Hawkes CA; Gentleman SM; Nicoll JA; Carare RO
J Pathol; 2015 Mar; 235(4):619-31. PubMed ID: 25345857
[TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy.
Weller RO; Cohen NR; Nicoll JA
Panminerva Med; 2004 Dec; 46(4):239-51. PubMed ID: 15876980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
